APELLIS PHARMACEUTICALS INC (APLS)       54.77  -1.96 (-3.45%)

54.77  -1.96 (-3.45%)

US03753U1060 - Common Stock - After market: 54.77 0 (0%)

TTM
(2022-9-30)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
2018
(2018-12-31)
Revenue
113.05M66.56M250.60M0.000.00
Non Recurring Items
-32.89M-100.59MN/A-1.50MN/A
Cost Of Goods
7.76M5.20M25.10MN/AN/A
Gross Profit
105.29M61.36M225.60MN/AN/A
Operating Expenses
625.25M597.64M439.30M288.00M127.90M
Operating Income
-519.96M-536.28M-213.70MN/AN/A
Interest Expense
-78.72M-110.50M-128.80M-15.00M500.00K
Income Before Taxes
-631.62M-746.00M-343.00M-304.70M-127.50M
Income Tax
2.49M352.00K1.80MN/A0.00
Net Income
-634.11M-746.35M-344.90M-304.70M-127.50M
EBITDA
-518.43M-534.90M-213.06MN/AN/A
 
Per Share Data
EPS Diluted Total Ops
-6.24-8.84-4.59-4.90-2.34
Non GAAP EPS
-6.24-8.93-4.72-4.86-2.33
 
Statistics
Gross Profit Margin
93.13%92.19%90.02%N/AN/A
Profit Margin
-560.92%-1121.27%-137.63%N/AN/A
Operating Profit Margin
-459.95%-805.67%-85.28%N/AN/A

All data in USD

Charts